At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
EksoGT with SmartAssist softwaredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Exoskeleton Treatment of Deconditioning Due to Limited Ambulation Caused by Illness or Injury
In Brief
A clinical study evaluating EksoGT with SmartAssist software for Debility Due to Disease. Completed, enrolled 15 participants across 3 sites.
Detailed Summary
A safety and feasibility study of robotic exoskeleton training in deconditioned patients residing in a healthcare facility.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDebility Due to Disease
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartOct 2017
First PostedNov 2017
Primary CompletionDec 2018
TodayJul 2026
First PostedNov 28, 2017
Enrollment StartOct 11, 2017
Primary CompletionDec 13, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.6 years ago
Interventions
EksoGT with SmartAssist softwaredevice
Intervention will consist of exercise using the EksoGT exoskeleton for supported walking. The EksoGT is a powered motorized orthosis intended to enable individuals who are experiencing muscular or neurological conditions affecting their lower extremities to perform ambulatory functions such as gait training.